Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19181844 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Cytokine-induced Memory-like NK Cells in Patients With Relapsed and Refractory AML
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Procedure: Leukapheresis;   Biological: Cytokine-induced killer cells;   Biological: Aldesleukin

Indicates status has not been verified in more than two years